TVIA / TerraVia Holdings, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

TVIA / TerraVia Holdings, Inc. / GLENHILL ADVISORS LLC - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment

SC 13G/A 1 d539561dsc13ga.htm AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* TERRAVIA HOLDINGS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 88105A106 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check

Material Modification to Rights of Security Holders, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2018 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation) (Commi

Combined Disclosure Statement and Plan of Liquidation of the Company.

EX-2.1 Exhibit 2.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) TERRAVIA HOLDINGS, INC., et al., ) Case No. 17-11655 (CSS) ) Debtors.1 ) Jointly Administered ) ) COMBINED DISCLOSURE STATEMENT AND CHAPTER 11 PLAN OF LIQUIDATION PROPOSED BY THE DEBTORS Dated: January 4, 2018 DAVIS POLK & WARDWELL LLP RICHARDS, LAYTON 450 Lexington Avenue & FINGER, P.A. N

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) TERRAVIA HOLDINGS, INC., et al.1 ) Case No. 17-11655 (CSS) ) Debtors. ) Jointly Administered ) ) Re: Docket No. 461 ORDER (I) APPROVING COMBINED DISCLOSURE STA

EX-99.1 Exhibit 99.1 IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) TERRAVIA HOLDINGS, INC., et al.1 ) Case No. 17-11655 (CSS) ) Debtors. ) Jointly Administered ) ) Re: Docket No. 461 ORDER (I) APPROVING COMBINED DISCLOSURE STATEMENT AND CHAPTER 11 PLAN OF LIQUIDATION PROPOSED BY THE DEBTORS AS CONTAINING ADEQUATE INFORMATION ON A FINAL BASIS AND (II) CO

Financial Statements and Exhibits, Other Events, Bankruptcy or Receivership

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2018 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation) (C

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 a171228tvia-x8xkfornovemb.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other

TerraVia Holdings, Inc. Monthly Operating Report, filed with the United States Bankruptcy Court for the District of Delaware on December 28, 2017

Exhibit Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1 Exhibit 99.1

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 a171205tvia-x8xkforoctobe.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other

TerraVia Holdings, Inc. Monthly Operating Report, filed with the United States Bankruptcy Court for the District of Delaware on November 30, 2017

Exhibit

TerraVia Holdings, Inc. Monthly Operating Report, filed with the United States Bankruptcy Court for the District of Delaware on November 1, 2017

Exhibit

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 tvia8-kformor9x30x17.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisd

TerraVia Holdings, Inc. Monthly Operating Report, filed with the United States Bankruptcy Court for the District of Delaware on October 3, 2017

Exhibit Exhibit 99.1

Regulation FD Disclosure, Financial Statements and Exhibits

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation) (C

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation)

Other Events

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation)

TerraVia Holdings, Inc. Key Employee Incentive Plan

Exhibit TERRAVIA HOLDINGS, INC. KEY EMPLOYEE INCENTIVE PLAN Section 1 . Purpose. The purpose of this Key Employee Incentive Plan (the ? Plan ?), to be implemented only upon a final order entered by the United States Bankruptcy Court for the District of the Delaware (such implementation date, the ? Effective Date ?), is to promote the interests of TerraVia Holdings, Inc. (the ? Company ?), a Delawa

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation) (C

TVIA / TerraVia Holdings, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D.

FIRST AMENDMENT TO LEASE

Exhibit FIRST AMENDMENT TO LEASE This First AMENDMENT TO LEASE (" First Amendment ") is made and entered into as of the 9th day of May, 2017, by and between BRITANNIA GATEWAY II LIMITED PARTNERSHIP, a Delaware limited partnership (" Landlord "), and TERRAVIA HOLDINGS, INC.

STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TERRAVIA HOLDINGS, INC.

Exhibit STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TERRAVIA HOLDINGS, INC.

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 a170828form8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

Exhibit AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this "Agreement" ) dated as of May 2, 2017 (the "Effective Date" ) between SILICON VALLEY BANK , a California corporation ( "Bank" ), and TERRAVIA HOLDINGS, INC.

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE

Exhibit IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE In re: TERRAVIA HOLDINGS, INC.

SENIOR SECURED SUPER-PRIORITY DEBTOR IN POSSESSION CREDIT AND SECURITY AGREEMENT Dated as of August 8, 2017 By and Among TERRAVIA HOLDINGS, INC., a Debtor and Debtor-in-Possession under Chapter 11 of the Bankruptcy Code, as Borrower, The Guarantors P

Exhibit SENIOR SECURED SUPER-PRIORITY DEBTOR IN POSSESSION CREDIT AND SECURITY AGREEMENT Dated as of August 8, 2017 By and Among TERRAVIA HOLDINGS, INC.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 form8-kdipfinancing.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdict

TVIA / TerraVia Holdings, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment

OMB APPROVAL OMB Number: 3235-0145 UNITED STATES Expires: February 28, 2009 SECURITIES AND EXCHANGE COMMISSION Estimated average burden hours per response.

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Other Events

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 28, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

FIRST SUPPLEMENTAL INDENTURE

Exhibit FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE dated as of July 28, 2017 (this ? Supplemental Indenture ?), among TerraVia Holdings, Inc.

Regulation FD Disclosure, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events, Bankruptcy or Receivership

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2017 TerraVia Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or other jurisdiction of incorporation) (Commission

TerraVia Holdings, Inc. Enters Into Agreement for the Sale of Substantially All of Its Assets Subject to Competitive Bidding Process TerraVia Files Voluntary Chapter 11 Petitions to Facilitate Sale Process with a Commitment for DIP Financing to Suppo

TerraVia Holdings, Inc. Enters Into Agreement for the Sale of Substantially All of Its Assets Subject to Competitive Bidding Process TerraVia Files Voluntary Chapter 11 Petitions to Facilitate Sale Process with a Commitment for DIP Financing to Support Ongoing Operations SAN FRANCISCO ? August 2, 2017 ? TerraVia Holdings, Inc. (NASDAQ:TVIA) (?TerraVia?), a next-generation food, nutrition and speci

STOCK AND ASSET PURCHASE AGREEMENT dated as of August 1, 2017 CORBION N.V. as the “Buyer” TERRAVIA HOLDINGS, INC., SOLAZYME MANUFACTURING 1, LLC as the “Sellers” TABLE OF CONTENTS

Exhibit 2.1 Execution Version STOCK AND ASSET PURCHASE AGREEMENT dated as of August 1, 2017 between CORBION N.V. as the ?Buyer? AND TERRAVIA HOLDINGS, INC., SOLAZYME MANUFACTURING 1, LLC as the ?Sellers? TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 6 Section 1.02. Other Definitional and Interpretative Provisions 18 ARTICLE 2 PURCHASE AND SALE Section 2.01. Purchase and Sa

Solazyme 8-K (Current Report/Significant Event)

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 24, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

Entry into a Material Definitive Agreement

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 17, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 26, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

Submission of Matters to a Vote of Security Holders

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 22, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commi

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 a8k170512.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 9, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorpo

TVIA / TerraVia Holdings, Inc. 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 00

Jonathan Wolfson Portola Valley, CA

Jonathan Wolfson Portola Valley, CA March 3, 2017 Apu Mody Chief Executive Officer TerraVia Holdings, Inc.

FORBEARANCE AGREEMENT

Exhibit FORBEARANCE AGREEMENT THIS FORBEARANCE AGREEMENT, dated as of May 3, 2017 (this ? Agreement ?), is entered into by and between TerraVia Holdings, Inc.

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 tvia2017-03x31xbodyearning.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 2, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisd

TerraVia Reports First Quarter 2017 Results

Exhibit Exhibit 99.1 TerraVia Reports First Quarter 2017 Results San Francisco, CA - May 3, 2017 - TerraVia (NASDAQ: TVIA), a next-generation food, nutrition and specialty ingredients company and pioneer in algae innovation, announced today financial results for the first quarter ended March 31, 2017. ?We met all of our commercial and operational goals for the first quarter as we executed against

Solazyme 8-K (Current Report/Significant Event)

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 7, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

Regulation FD Disclosure

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 3, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Comm

Costs Associated with Exit or Disposal Activities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 29, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Com

Solazyme DEFA14A

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)

Solazyme DEF 14A

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)

Solazyme PRE 14A

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: x Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)

List of Subsidiaries Name of Subsidiary State or Jurisdiction in Which Incorporated or Organized Solazyme Brazil, LLC Delaware Solazyme Brasil Oleos Renovaveis e Bioprodutos LTDA Brazil Solazyme Manufacturing 1, LLC Delaware Solazyme Bunge Renewable

Exhibit 21.1 List of Subsidiaries Name of Subsidiary State or Jurisdiction in Which Incorporated or Organized Solazyme Brazil, LLC Delaware Solazyme Brasil Oleos Renovaveis e Bioprodutos LTDA Brazil Solazyme Manufacturing 1, LLC Delaware Solazyme Bunge Renewable Oils Coöperatief U.A.* The Netherlands * The above-named subsidiary has two consolidated wholly-owned subsidiaries operating in foreign c

TVIA / TerraVia Holdings, Inc. 10-K (Annual Report)

Table Of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 001-35

FINANCIAL STATEMENTS OF SIGNIFICANT EQUITY METHOD INVESTEE SOLAZYME BUNGE RENEWABLE OILS COOPERATIEF U.A. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

FINANCIAL STATEMENTS OF SIGNIFICANT EQUITY METHOD INVESTEE SOLAZYME BUNGE RENEWABLE OILS COOPERATIEF U.

Statement of Computation of Ratio of Earnings to Fixed Charges (In thousands) Year Ended December 31, 2016 2015 2014 2013 2012 Earnings: Loss from continuing operations before income taxes $ (106,919 ) $ (138,382 ) $ (161,161 ) $ (117,112 ) $ (80,280

Exhibit 12.1 Statement of Computation of Ratio of Earnings to Fixed Charges (In thousands) Year Ended December 31, 2016 2015 2014 2013 2012 Earnings: Loss from continuing operations before income taxes $ (106,919 ) $ (138,382 ) $ (161,161 ) $ (117,112 ) $ (80,280 ) Loss from equity method investments 22,391 22,389 23,037 8,237 1,824 Fixed charges 13,545 14,160 16,535 7,136 978 Capitalized interest

TerraVia Reports Fourth Quarter and Full Year 2016 Results

EX-99.1 Exhibit 99.1 TerraVia Reports Fourth Quarter and Full Year 2016 Results San Francisco, CA ? March 8, 2017 ? TerraVia (NASDAQ: TVIA), a next-generation food, nutrition and specialty ingredients company and pioneer in algae innovation, announced today results for the fourth quarter and full year ended December 31, 2016. ?2016 proved to be a defining year for TerraVia in streamlining around f

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 3, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fi

Regulation FD Disclosure

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 24, 2017 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (

TVIA / TerraVia Holdings, Inc. / GLENHILL ADVISORS LLC - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* TERRAVIA HOLDINGS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 88105A106 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to

TVIA / TerraVia Holdings, Inc. / Passport Capital, LLC - FORM SC 13G/A Passive Investment

SC 13G/A 1 sched13gatvia.htm FORM SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* TerraVia Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 88105A106 (CUSIP Number) December 31, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box t

TVIA / TerraVia Holdings, Inc. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment

SC 13G/A 1 a17-398654sc13ga.htm SC 13G/A UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D.C. 20549 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . .10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* TerraVia Holdings, Inc. (Name of Issuer) Common (Title of Class of Securities) 88105A106

Regulation FD Disclosure, Unregistered Sales of Equity Securities

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 23, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commi

TerraVia Holdings 10-Q (Quarterly Report)

10-Q 1 tvia2016-09x30x10xq.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition

TERRAVIA HOLDINGS, INC. $25,000,000 COMMON STOCK SALES AGREEMENT

TERRAVIA HOLDINGS, INC. $25,000,000 COMMON STOCK SALES AGREEMENT August 8, 2016 Cowen and Company, LLC 599 Lexington Avenue New York, NY 10022 Ladies and Gentlemen: TerraVia Holdings, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: 1. Issuance and Sale of Shares. The Company agrees that, from time to time during the term of this Ag

CONTRIBUTION AGREEMENT dated as of August 2, 2016 between TCP ALGENIST LLC, ALGENIST HOLDINGS, INC., and TERRAVIA HOLDINGS, INC. TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 2 Section 1.01 Definitions 2 Section 1.02 Other Definitional and Interpretat

Execution Version CONTRIBUTION AGREEMENT dated as of August 2, 2016 between TCP ALGENIST LLC, ALGENIST HOLDINGS, INC.

TerraVia Holdings, Inc., 225 Gateway Boulevard, South San Francisco, California 94080

[TerraVia logo] July 27, 2016 Apurva S. Mody Dear Apurva, TerraVia Holdings, Inc. (the “Company”) is pleased to offer you employment as Chief Executive Officer (the “CEO”) of the Company on the terms set forth in this offer letter, contingent on my completing references and receiving formal approval from TerraVia’s Compensation Committee. As CEO, you will have all of the duties, authority and resp

TerraVia Reports Third Quarter 2016 Results

EX-99.1 Exhibit 99.1 TerraVia Reports Third Quarter 2016 Results San Francisco, CA ? November 2, 2016 ? TerraVia (NASDAQ: TVIA), a next-generation food, nutrition and specialty ingredients company and pioneer in algae innovation, announced today results for the third quarter ended September 30, 2016. ?I believe we are in an important moment for innovation in the food industry. TerraVia?s revolutio

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 2, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commis

Unregistered Sales of Equity Securities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 14, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation)

Unregistered Sales of Equity Securities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 19, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Co

Unregistered Sales of Equity Securities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 19, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Co

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 16, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Co

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Com

$25,000,000 Common Stock

424B5 1 d222008d424b5.htm PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-212448 PROSPECTUS SUPPLEMENT (To Prospectus dated August 5, 2016) $25,000,000 Common Stock We have entered into a sales agreement with Cowen and Company, LLC, or Cowen, as our sales agent, relating to shares of our common stock, $0.001 par value p

TERRAVIA HOLDINGS, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

EX-99.2 Exhibit 99.2 TERRAVIA HOLDINGS, INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS On August 2, 2016, TerraVia Holdings, Inc. (?TerraVia? or the ?Company?) entered into a Contribution Agreement (the ?Agreement?) to sell a majority interest in its Algenist skincare business (?Algenist?) to a third party private equity firm. The Company will receive $20.2 million in cash (s

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 2, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Com

Tengram Capital Partners to Acquire Majority Interest of Prestige Skincare Brand Algenist and Announces Broader Beauty and Personal Care Partnership with TerraVia Leading consumer private equity firm Tengram to partner with TerraVia to grow Algenist

EX-99.1 Exhibit 99.1 Tengram Capital Partners to Acquire Majority Interest of Prestige Skincare Brand Algenist and Announces Broader Beauty and Personal Care Partnership with TerraVia Leading consumer private equity firm Tengram to partner with TerraVia to grow Algenist as part of beauty and personal care partnership leveraging TerraVia?s proprietary algae-based ingredient platform San Francisco,

TerraVia Holdings 10-Q (Quarterly Report)

Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Com

TerraVia Reports Second Quarter 2016 Results Strong progress in commercialization, production and product development Algenist transaction and appointment of new CEO affirm path toward broad commercialization of food, nutrition and specialty ingredie

EX-99.1 2 d233557dex991.htm EX-99.1 Exhibit 99.1 TerraVia Reports Second Quarter 2016 Results Strong progress in commercialization, production and product development Algenist transaction and appointment of new CEO affirm path toward broad commercialization of food, nutrition and specialty ingredients business San Francisco, CA – August 8, 2016 – TerraVia (NASDAQ: TVIA), a next-generation food, nu

LOAN AND SECURITY AGREEMENT

EXECUTION VERSION LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of June 28, 2016 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and TERRAVIA HOLDINGS, INC.

TO: SILICON VALLEY BANK DATE FOR BANK USE ONLY LETTER OF CREDIT NO. • APPLICATION April 12, 2016 APPLICANT HEREBY REQUESTS THAT SILICON VALLEY BANK (“SVB”) ISSUE ITS IRREVOCABLE STANDBY LETTER OF CREDIT (THE “CREDIT’) ON SUBSTANTIALLY TILE TERMS BELO

Application and Agreement for Standby Letter of Credit TO: SILICON VALLEY BANK DATE FOR BANK USE ONLY LETTER OF CREDIT NO.

BRL 35,356,350.50*0.2859= $12,635,350.50

BRL 35,356,350.50*0.2859= $12,635,350.50 Bloomberg exchange rate on April 12, 2016 Bank Services Pledge Agreement (Cash-Secured) Applicant: Solazyme, Inc. Date: April 12, 2016 ☒ Authorizes Silicon Valley Bank (the “Bank”) to debit the amount of $12,635,350.50 from the Account Number to establish the Collateral Money Market Account (the “Deposit Account”) for the following requested Bank Services:

Solazyme ESP

CORRESP TerraVia Holdings, Inc. 225 Gateway Boulevard South San Francisco, CA 94080 August 3, 2016 VIA EDGAR Re: TerraVia Holdings, Inc. (the ?Registrant?) Registration Statement on Form S-3 Registration No. 333-212448 Request for Acceleration Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Pamela Long Dear Ms. Long: In accord

STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TERRAVIA HOLDINGS, INC.

EX-3.3 Exhibit 3.3 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF TERRAVIA HOLDINGS, INC. The undersigned, Jonathan S. Wolfson, hereby certifies that: ONE: He is the duly elected and acting Chief Executive Officer of TerraVia Holdings, Inc., a corporation organized and existing under the laws of the State of Delaware. TWO: The original Certificat

Statement of Computation of Ratio of Earnings to Fixed Charges and Ratio of Combined Fixed Charges and Preference Dividends to Earnings (In thousands) Three Months Ended March 31, Year Ended December 31, 2016 2015 2015 2014 2013 2012 2011 Earnings: C

EX-12.1 Exhibit 12.1 Statement of Computation of Ratio of Earnings to Fixed Charges and Ratio of Combined Fixed Charges and Preference Dividends to Earnings (In thousands) Three Months Ended March 31, Year Ended December 31, 2016 2015 2015 2014 2013 2012 2011 Earnings: Consolidated net loss before income tax (26,512 ) (34,665 ) $ (141,447 ) $ (162,141 ) $ (116,389 ) $ (83,132 ) $ (53,961 ) Loss on

TerraVia Holdings FORM S-3

S-3 1 d222008ds3.htm FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on July 8, 2016 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TerraVia Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 33-1077078 (State or Other Jurisdiction of Incorpo

[FORM OF SENIOR INDENTURE] TERRAVIA HOLDINGS, INC., Issuer Wells Fargo Bank, National Association, Trustee Dated as of [●], 201[●] SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Certain Terms Defined; Rules of Const

EX-4.2 Exhibit 4.2 [FORM OF SENIOR INDENTURE] TERRAVIA HOLDINGS, INC., Issuer and Wells Fargo Bank, National Association, Trustee INDENTURE Dated as of [?], 201[?] SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Certain Terms Defined; Rules of Construction 1 ARTICLE 2 SECURITIES Section 2.01. Forms Generally 6 Section 2.02. Form of Trustee?s Certification of Authe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

EX-25.1 8 d222008dex251.htm EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as s

FORM OF NOTE DUE

EX-4.3 Exhibit 4.3 FORM OF NOTE DUE [UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (?DTC?), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS M

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 5, 2016 (April 29, 2016) Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (S

Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commi

Joint Filing Agreement

EX-99.1 Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k)(l) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing on behalf of each of them (and their affiliates) of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of TerraVia Holdings, Inc. and that this agreement be included

TVIA / TerraVia Holdings, Inc. / GLENHILL ADVISORS LLC - SCHEDULE 13G Passive Investment

SC 13G 1 d194103dsc13g.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TERRAVIA HOLDINGS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 88105A106 (CUSIP Number) May 16, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa

STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SOLAZYME, INC.

SEC Exhibit STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SOLAZYME, INC.

Solazyme 8-K (Current Report/Significant Event)

SEC Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 9, 2016 Date of report (Date of earliest event reported) TERRAVIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Co

AMENDED AND RESTATED BYLAWS OF TERRAVIA HOLDINGS, INC. * * * * * Article 1 OFFICES

SEC Exhibit AMENDED AND RESTATED BYLAWS OF TERRAVIA HOLDINGS, INC. * * * * * Article 1 OFFICES Section 1.01 . Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.02 . Other Offices. The Corporation may also have offices at such other places both within and without the State of Delaware as the Board of Di

Solazyme 10-Q (Quarterly Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 0

AMENDMENT NO. 1 TO Series A Convertible Preferred Stock Purchase Agreement March 14, 2016

AMENDMENT NO. 1 TO Series A Convertible Preferred Stock Purchase Agreement March 14, 2016 This Amendment No. 1 (this “Amendment”) to that certain Series A Convertible Preferred Stock Purchase Agreement, dated March 10, 2016 (the “Agreement”), by and among Solazyme, Inc., a Delaware corporation (the “Company”), and each of those persons and entities whose names are set forth on Schedule A to the SP

FORM OF STANDSTILL AGREEMENT

FORM OF STANDSTILL AGREEMENT This STANDSTILL AGREEMENT (this “Agreement”) dated as of [], 2016 is between Solazyme, Inc.

SOLAZYME, INC. SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT March 10, 2016 TABLE OF CONTENTS Page Article 1 Authorization and Sale of Series A CONVERTIBLE Preferred Stock Section 1.01. Authorization of Series A Convertible Preferred Stock

EXECUTION VERSION SOLAZYME, INC. SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT March 10, 2016 TABLE OF CONTENTS Page Article 1 Authorization and Sale of Series A CONVERTIBLE Preferred Stock Section 1.01. Authorization of Series A Convertible Preferred Stock 1 Section 1.02. Sale of Series A Preferred Stock 1 Article 2 Closing Date; Delivery Section 2.01. Closing Date. 1 Section 2.02. Deli

REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the date set forth on the Company signature page hereto, among Solazyme, Inc.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Results of Operations and Financial Condition

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 29, 2016 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission F

TerraVia Reports First Quarter 2016 Results Announces launch of AlgaPrime™ DHA and signs supply agreement with global aquaculture leader

EX-99.1 Exhibit 99.1 TerraVia Reports First Quarter 2016 Results Announces launch of AlgaPrime? DHA and signs supply agreement with global aquaculture leader San Francisco, CA ? May 4, 2016 ? TerraVia? (Solazyme, Inc.) (NASDAQ: SZYM), a pioneer in algae innovation and a food, nutrition and specialty ingredients company, announced today results for the first quarter ended March 31, 2016. ?TerraVia?

Solazyme DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Solazyme DEF 14A

DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Solazyme DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Solazyme PRE 14A

PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Unregistered Sales of Equity Securities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 24, 2016 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission F

CERTIFICATE OF DESIGNATIONS OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK OF SOLAZYME, INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware

Exhibit 3.1 Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK OF SOLAZYME, INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware The undersigned, Jonathan S. Wolfson, hereby certifies that: 1. He is the duly elected and acting Chief Executive Officer of Solazyme, Inc., a corporation (the ?Corporatio

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 14, 2016 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission F

Solazyme S-8

S-8 As filed with the Securities and Exchange Commission on March 14, 2016 Registration No.

Solazyme 10-K (Annual Report)

10-K Table Of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

AMENDED AND RESTATED JOINT VENTURE AGREEMENT

Exhibit 10.23 AMENDED AND RESTATED JOINT VENTURE AGREEMENT This Amended and Restated Joint Venture Agreement (“Agreement”) is entered into as of October 27, 2015 (the “Effective Date”), by and among, Bunge Global Innovation, LLC, a Delaware limited liability company, with a place of business at 50 Main Street, White Plains, NY 10606 (“BGI”), Bunge Coöperatief UA, a Dutch cooperative, with a princi

List of Subsidiaries Name of Subsidiary State or Jurisdiction in Which Incorporated or Organized Solazyme Brazil, LLC Delaware Solazyme Brasil Oleos Renovaveis e Bioprodutos LTDA Brazil Solazyme Manufacturing 1, LLC Delaware

Exhibit 21.1 List of Subsidiaries Name of Subsidiary State or Jurisdiction in Which Incorporated or Organized Solazyme Brazil, LLC Delaware Solazyme Brasil Oleos Renovaveis e Bioprodutos LTDA Brazil Solazyme Manufacturing 1, LLC Delaware 1

Statement of Computation of Ratio of Earnings to Fixed Charges and Ratio of Combined Fixed Charges and Preferred Stock Dividends to Earnings (In thousands) Year Ended December 31, 2015 2014 2013 2012 2011 Earnings: Consolidated net loss before income

Exhibit 12.1 Statement of Computation of Ratio of Earnings to Fixed Charges and Ratio of Combined Fixed Charges and Preferred Stock Dividends to Earnings (In thousands) Year Ended December 31, 2015 2014 2013 2012 2011 Earnings: Consolidated net loss before income tax $ (141,447 ) $ (162,141 ) $ (116,389 ) $ (83,132 ) $ (53,961 ) Loss on equity method investment 22,389 23,037 8,237 1,824 — Fixed ch

AMENDED AND RESTATED SOLAZYME DEVELOPMENT AGREEMENT

AMENDED AND RESTATED SOLAZYME DEVELOPMENT AGREEMENT This Amended and Restated Solazyme Development Agreement (“Agreement”) is entered into as of October 27, 2015 (the “Effective Date”), by and among Solazyme Bunge Renewable Oils Coöperatief U.

TerraVia (Solazyme) Reports Fourth Quarter and Full Year 2015 Results New 5-year Supply Agreement with Unilever Aligns with Company’s Transition to Food, Nutrition and Specialty Ingredients

EX-99.1 Exhibit 99.1 TerraVia (Solazyme) Reports Fourth Quarter and Full Year 2015 Results New 5-year Supply Agreement with Unilever Aligns with Company?s Transition to Food, Nutrition and Specialty Ingredients South San Francisco, CA ? March 14, 2016 ? Solazyme, Inc. (NASDAQ: SZYM), now known as TerraVia?, a pioneer in algae innovation and a food, nutrition and specialty ingredients company, anno

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 9, 2016 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File Nu

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 8, 2016 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fi

EX-24

Exhibit 24 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Tyler Painter, Paul Quinlan, Megan Comport, Rob Maynes and Diana Kwon as the undersigned's true and lawful attorneys-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a reporting person pursuant to Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder of Solazyme, Inc.

Regulation FD Disclosure, Unregistered Sales of Equity Securities

8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 18, 2016 (December 28, 2015) Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisd

Costs Associated with Exit or Disposal Activities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 29, 2016 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission

Solazyme FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 28, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commissio

Solazyme ESP

CORRESP November 20, 2015 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

[Solazyme, Inc. Letterhead]

EX-10.1 Exhibit 10.1 [Solazyme, Inc. Letterhead] October 29, 2015 Archer-Daniels-Midland Company 4666 Faries Parkway Decatur, Illinois 62526 Attn: Kevin Moore By Federal Express Re: Termination of Operating Agreement by and between Solazyme, Inc. (?Solazyme?) and Archer-Daniels-Midland Company (?ADM?) entered into as of November 13, 2012 (the ?Operating Agreement?) Dear Sir/Madame: Solazyme hereby

Solazyme Reports Third Quarter 2015 Results Expands Joint Venture with Bunge and Adds New Oil Development Project with Unilever

EX-99.1 Exhibit 99.1 Solazyme Reports Third Quarter 2015 Results Expands Joint Venture with Bunge and Adds New Oil Development Project with Unilever South San Francisco, CA ? October 30, 2015 ? Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and specialty ingredients company, announced today results for the third quarter ended September 30, 2015. ?At Solazyme, we are committed to improving the live

Solazyme 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 30, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 29, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission

Solazyme ESP

CORRESP FOIA Confidential Treatment Request Confidential treatment requested by Solazyme, Inc.

Solazyme ESP

CORRESP August 13, 2015 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

Solazyme Reports Second Quarter 2015 Results

EX-99.1 Exhibit 99.1 Solazyme Reports Second Quarter 2015 Results South San Francisco, CA ? July 30, 2015 ? Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and specialty ingredients company, announced today results for the second quarter ended June 30, 2015. ?We are making good progress against our core deliverables, the commercialization of high value products across food, personal care and indust

Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 30, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fi

Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 14, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fil

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 6, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File Numb

Solazyme Reports First Quarter 2015 Results

EX-99.1 Exhibit 99.1 Solazyme Reports First Quarter 2015 Results South San Francisco, CA ? May 6, 2015 ? Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results for the first quarter ended March 31, 2015. ?We are executing against our operating plan for 2015 and are pleased with the progress we are seeing across the company and in our manufacturing and comme

TerraVia Holdings DEFA14A

DEFA14A 1 d897679ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as

TerraVia Holdings DEFINITIVE PROXY STATEMENT

Definitive Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

TerraVia Holdings S-8

S-8 1 d883156ds8.htm S-8 As filed with the Securities and Exchange Commission on March 6, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Solazyme, Inc. (Exact name of registrant as specified in its charter) Delaware 33-1077078 (State or other jurisdiction of incorporation or organiz

TVIA / TerraVia Holdings, Inc. NT 10-K - - NT 10-K

NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2014 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 25, 2015 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fil

Solazyme Reports Fourth Quarter and Full Year 2014 Results Continued progress at Solazyme Bunge Renewable Oils plant

EX-99.1 Exhibit 99.1 Solazyme Reports Fourth Quarter and Full Year 2014 Results Continued progress at Solazyme Bunge Renewable Oils plant South San Francisco, CA – February 26, 2015 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results for the fourth quarter and full year ended December 31, 2014. “Although 2014 was a challenging year, we made great strid

TVIA / TerraVia Holdings, Inc. SC TO-I/A - - AMENDMENT NO. 2 TO SCHEDULE TO-I

Amendment No. 2 to Schedule TO-I SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to SCHEDULE TO (Rule 13e-4) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 SOLAZYME, INC. (Name Of Subject Company (Issuer) and Filing Person (Offeror)) OPTIONS TO PURCHASE COMMON STOCK, PAR VALUE $0.001 PER SHARE, WITH AN EXERCISE PRICE EQUAL

TVIA / TerraVia Holdings, Inc. / Passport Capital, LLC - FORM SC 13G/A Passive Investment

Passport Capital, LLC: Form SC 13G/A - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of this Statement) Check the appr

TVIA / TerraVia Holdings, Inc. / Fiddler Jerry - SC 13G/A (AMENDMENT NO. 3) Passive Investment

SC 13G/A (Amendment No. 3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs

TVIA / TerraVia Holdings, Inc. CORRESP - -

CORRESP 1 filename1.htm February 3, 2015 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Lisa M. Kohl, Attorney-Advisor, Office of Mergers & Acquisitions Re: Solazyme, Inc. Schedule TO-I Filed January 21, 2015 File No. 005-86676 Ladies and Gentlemen: Solazyme, Inc. (the “Company”) is submitting this letter in response to comme

TVIA / TerraVia Holdings, Inc. SC TO-I/A - - AMENDMENT NO. 1 TO SCHEDULE TO-I

SC TO-I/A 1 d864217dsctoia.htm AMENDMENT NO. 1 TO SCHEDULE TO-I SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to SCHEDULE TO (Rule 13e-4) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 SOLAZYME, INC. (Name Of Subject Company (Issuer) and Filing Person (Offeror)) OPTIONS TO PURCHASE COMMON STOCK, PAR VALUE $0.001 PER SHAR

SOLAZYME, INC. OFFER TO EXCHANGE CERTAIN OUTSTANDING STOCK OPTIONS NEW STOCK OPTIONS THIS OFFER AND YOUR WITHDRAWAL RIGHTS EXPIRE AT 9:00 P.M., U.S. PACIFIC TIME, ON FEBRUARY 18, 2015, UNLESS WE EXTEND THE OFFER. The Date of this Offer is January 21,

EX-99.(A)(1)(A) Exhibit 99.(a)(1)(A) SOLAZYME, INC. OFFER TO EXCHANGE CERTAIN OUTSTANDING STOCK OPTIONS FOR NEW STOCK OPTIONS THIS OFFER AND YOUR WITHDRAWAL RIGHTS EXPIRE AT 9:00 P.M., U.S. PACIFIC TIME, ON FEBRUARY 18, 2015, UNLESS WE EXTEND THE OFFER. The Date of this Offer is January 21, 2015 Solazyme, Inc. (“Solazyme”) is offering eligible employees the opportunity to exchange, on a grant-by-g

TVIA / TerraVia Holdings, Inc. SC TO-I - - SC TO-I

SC TO-I SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (Rule 13e-4) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 SOLAZYME, INC. (Name Of Subject Company (Issuer) and Filing Person (Offeror)) OPTIONS TO PURCHASE COMMON STOCK, PAR VALUE $0.001 PER SHARE, WITH AN EXERCISE PRICE EQUAL TO OR GREATER THAN $6.79 PER SHARE (Title o

FORM OF EMAIL CONFIRMING RECEIPT OF ELECTION FORM TO: [Employee] FROM: Idalina Chan SUBJECT: Stock Option Exchange Program—Election Confirmation

EX-99.(A)(1)(F) 7 d851869dex99a1f.htm EX-99.(A)(1)(F) Exhibit 99.(a)(1)(F) FORM OF EMAIL CONFIRMING RECEIPT OF ELECTION FORM TO: [Employee] FROM: Idalina Chan SUBJECT: Stock Option Exchange Program—Election Confirmation Thank you for your submission of your election to participate in our stock option exchange program. The election made in the attached Election Form has been recorded. We strongly e

FORM OF REMINDER EMAIL COMMUNICATIONS FROM: Paul Quinlan, General Counsel SUBJECT: Option Exchange Deadline Approaching

EX-99.(A)(1)(G) 8 d851869dex99a1g.htm EX-99.(A)(1)(G) Exhibit 99.(a)(1)(G) FORM OF REMINDER EMAIL COMMUNICATIONS FROM: Paul Quinlan, General Counsel SUBJECT: Option Exchange Deadline Approaching This email is to remind you that February 18, 2015 at 9:00 p.m. Pacific Time is the final deadline to elect to participate in the exchange program. If you wish to exchange your eligible stock options for r

ELECTION FORM

EX-99.(A)(1)(B) 3 d851869dex99a1b.htm EX-99.(A)(1)(B) Exhibit 99.(a)(1)(B) ELECTION FORM I have received the Offer to Exchange dated January 21, 2015, this Election Form, the form of Stock Option Agreement (such form or an agreement with substantially similar terms being referred to herein as the “Agreement”) and the 2011 Equity Incentive Plan (the “2011 Plan”). By completing, signing and deliveri

FORM OF EXCHANGE OFFER ANNOUNCEMENTS TO: All Solazyme, Inc. Employees FROM: Paul Quinlan, General Counsel SUBJECT: IMPORTANT NEWS: Launch of Stock Option Exchange Program DATE: January 21, 2015

EX-99.(A)(1)(D) 5 d851869dex99a1d.htm EX-99.(A)(1)(D) Exhibit 99.(a)(1)(D) FORM OF EXCHANGE OFFER ANNOUNCEMENTS TO: All Solazyme, Inc. Employees FROM: Paul Quinlan, General Counsel SUBJECT: IMPORTANT NEWS: Launch of Stock Option Exchange Program DATE: January 21, 2015 IMPORTANT NEWS — PLEASE READ IMMEDIATELY. SHOULD YOU CHOOSE TO PARTICIPATE IN THIS PROGRAM, YOU MUST TAKE ACTION BY 9:00 P.M., PACI

NOTICE OF WITHDRAWAL OF OPTIONS PREVIOUSLY TENDERED FOR EXCHANGE

EX-99.(A)(1)(C) 4 d851869dex99a1c.htm EX-99.(A)(1)(C) Exhibit 99.(a)(1)(C) NOTICE OF WITHDRAWAL OF OPTIONS PREVIOUSLY TENDERED FOR EXCHANGE IMPORTANT: Use this form if you previously returned an Election Form tendering your stock options for exchange, and you wish to withdraw all or some of the options you previously elected to exchange. ¨ I want to withdraw all of the options I previously elected

SOLAZYME, INC. OFFER TO EXCHANGE CERTAIN OUTSTANDING STOCK OPTIONS NEW STOCK OPTIONS THIS OFFER AND YOUR WITHDRAWAL RIGHTS EXPIRE AT 9:00 P.M., U.S. PACIFIC TIME, ON FEBRUARY 18, 2015, UNLESS WE EXTEND THE OFFER. The Date of this Offer is January 21,

EX-99.(A)(1)(A) 2 d851869dex99a1a.htm EX-99.(A)(1)(A) Exhibit 99.(a)(1)(A) SOLAZYME, INC. OFFER TO EXCHANGE CERTAIN OUTSTANDING STOCK OPTIONS FOR NEW STOCK OPTIONS THIS OFFER AND YOUR WITHDRAWAL RIGHTS EXPIRE AT 9:00 P.M., U.S. PACIFIC TIME, ON FEBRUARY 18, 2015, UNLESS WE EXTEND THE OFFER. The Date of this Offer is January 21, 2015 Solazyme, Inc. (“Solazyme”) is offering eligible employees the op

FORM OF CONFIRMATION OF PARTICIPATION IN THE OPTION EXCHANGE OFFER TO: FROM: [Employee] Idalina Chan SUBJECT: Confirmation of Acceptance of Election to Participate in Exchange Offer

EX-99.(A)(1)(H) 9 d851869dex99a1h.htm EX-99.(A)(1)(H) Exhibit 99.(a)(1)(H) FORM OF CONFIRMATION OF PARTICIPATION IN THE OPTION EXCHANGE OFFER TO: FROM: [Employee] Idalina Chan SUBJECT: Confirmation of Acceptance of Election to Participate in Exchange Offer Thank you for your submission of your election to participate in the exchange offer. We confirm with this email that we have accepted your elec

OPTION EXCHANGE PROGRAM

EX-99.(A)(1)(E) 6 d851869dex99a1e.htm EX-99.(A)(1)(E) OPTION EXCHANGE PROGRAM OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS FOR NEW STOCK OPTIONS Exhibit 99.(a)(1)(E) 2 PURPOSE OF THE PRESENTATION • Remind Zymers of the key dates and terms of the Exchange Offer • Provide you with considerations for your decision making • Illustrate what terms mean • Review exchange mechanics • Ensure you know wher

FORM OF COMMUNICATION REGARDING THE RESULTS OF THE OPTION EXCHANGE OFFER TO: FROM: Solazyme Employees Paul Quinlan SUBJECT: Results of the Option Exchange Offer

EX-99.(A)(1)(I) 10 d851869dex99a1i.htm EX-99.(A)(1)(I) Exhibit 99.(a)(1)(I) FORM OF COMMUNICATION REGARDING THE RESULTS OF THE OPTION EXCHANGE OFFER TO: FROM: Solazyme Employees Paul Quinlan SUBJECT: Results of the Option Exchange Offer The option exchange offer expired at 9:00 p.m., Pacific Time, on February 18, 2015. Pursuant to the exchange offer, eligible option holders tendered, and Solazyme

Costs Associated with Exit or Disposal Activities

8-K 1 d840475d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 18, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Inco

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 13, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fil

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 5, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File

Solazyme Reports Third Quarter 2014 Results

EX-99.1 Exhibit 99.1 Solazyme Reports Third Quarter 2014 Results South San Francisco, CA – November 5, 2014 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results for the third quarter ended September 30, 2014. “Solazyme made continued progress in manufacturing and commercial activity in the third quarter,” said Jonathan Wolfson, CEO of Solazyme. “Our Cli

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) September 17, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

TVIA / TerraVia Holdings, Inc. / Passport Capital, LLC - SCHEDULE 13G Passive Investment

Passport Capital, LLC: Schedule 13G/A - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) September 30, 2014 (Date of Event which Requires Filing of this Statement) Check the ap

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 d803163d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 9, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorp

Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 30, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fi

Solazyme Reports Second Quarter 2014 Results

EX-99.1 2 d766670dex991.htm EX-99.1 Exhibit 99.1 Solazyme Reports Second Quarter 2014 Results South San Francisco, CA – July 30, 2014 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results for the second quarter ended June 30, 2014. “Solazyme made important progress in the second quarter on its commercialization path,” said Jonathan Wolfson, CEO of Solazy

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 22, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 1, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fil

Unregistered Sales of Equity Securities - 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 19, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File Nu

-

CORRESP June 12, 2014 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

Submission of Matters to a Vote of Security Holders - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 22, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fil

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File

Solazyme Reports First Quarter 2014 Results

EX-99.1 Exhibit 99.1 Solazyme Reports First Quarter 2014 Results South San Francisco, CA – May 5, 2014 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results for the first quarter ended March 31, 2014. “Q1 was an important milestone quarter for the company from both production and commercialization standpoints as we began making and selling products from

- DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

- DEF14A

DEF14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

TVIA / TerraVia Holdings, Inc. / Passport Capital, LLC - FORM SC 13G Passive Investment

Passport Capital, LLC - Schedule 13G - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) March 26, 2014 (Date of Event which Requires Filing of this Statement) Check the appropri

Solazyme, Inc. Wells Fargo Bank, National Association, as Trustee Dated as of April 1, 2014 5.00% Convertible Senior Subordinated Notes due 2019 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 2 Section 1.02. References to Inte

EX-4.1 2 d704811dex41.htm EX-4.1 Exhibit 4.1 Solazyme, Inc. AND Wells Fargo Bank, National Association, as Trustee INDENTURE Dated as of April 1, 2014 5.00% Convertible Senior Subordinated Notes due 2019 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 2 Section 1.02. References to Interest 13 Section 1.03. Incorporation by Reference of Trust Indenture Act 13 ARTICLE 2 ISSUE,

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K

Prepared by R.R. Donnelley Financial - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 1, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdictio

Financial Statements and Exhibits, Other Events - 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File N

Solazyme, Inc. 5,000,000 Shares of Common Stock Underwriting Agreement

EX-99.1 Exhibit 99.1 Execution Version Solazyme, Inc. 5,000,000 Shares of Common Stock Underwriting Agreement March 26, 2014 Goldman, Sachs & Co. Morgan Stanley & Co. LLC As representatives of the several Underwriters named in Schedule I hereto, Goldman, Sachs & Co. 200 West Street New York, New York 10282 Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036 Ladies and Gentlemen: Solazyme, In

Solazyme, Inc. Concurrent Offerings of 5,000,000 Shares of Common Stock (the “Common Stock Offering”) $130,000,000 5.00% Convertible Senior Subordinated Notes due 2019 (the “Convertible Notes Offering”)

FWP Issuer Free Writing Prospectus dated March 26, 2014 Filed Pursuant to Rule 433 Registration No.

Solazyme, Inc. 5.00% Convertible Senior Subordinated Notes due 2019 Underwriting Agreement March 26, 2014

EX-99.2 Exhibit 99.2 Execution Version Solazyme, Inc. 5.00% Convertible Senior Subordinated Notes due 2019 Underwriting Agreement March 26, 2014 Goldman, Sachs & Co. 200 West Street, New York, New York 10282-2198 Ladies and Gentlemen: Solazyme, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this Underwriting Agreement (this “Agreement”), to is

CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount To Be Registered Maximum Offering Price per Unit Maximum Aggregate Offering Price(2) Amount of Registration Fee(2) 5.00% Convertible Senior Subordinated Notes d

424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-194808 Registration No. 333-194834 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount To Be Registered Maximum Offering Price per Unit Maximum Aggregate Offering Price(2) Amount of Registration Fee(2) 5.00% Convertible Senior Subordinated Notes due 2019 $149,500,000(1) 100% $149,500

CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount To Be Registered Maximum Offering Price per Share Maximum Aggregate Offering Price Amount of Registration Fee(2) Common Stock, $0.001 par value per share 5,750,

424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-194808 Registration No. 333-194834 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to be Registered Amount To Be Registered Maximum Offering Price per Share Maximum Aggregate Offering Price Amount of Registration Fee(2) Common Stock, $0.001 par value per share 5,750,000(1) $11.00 $63,250,000 $8,146.60 (

- S-3MEF

S-3MEF As filed with the Securities and Exchange Commission on March 26, 2014 Registration No.

Consolidated net loss before income tax

EX-12.1 Exhibit 12.1 Statement of Computation of Ratio of Earnings to Fixed Charges (In thousands) Year Ended December 31, 2013 2012 2011 2010 2009 Earnings: Consolidated net loss before income tax $ (116,389 ) $ (83,132 ) $ (53,961 ) $ (16,420 ) $ (13,815 ) Loss on equity method investment 8,237 1,824 — — — Fixed charges 9,911 978 764 288 609 Capitalized interest, net of amortization (1,055 ) (27

Solazyme, Inc. Wells Fargo Bank, National Association, as Trustee Dated as of April [ ], 2014 [ ]% Convertible Senior Subordinated Notes due 2019 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 2 Section 1.02. References to Int

EX-4.2 Exhibit 4.2 Solazyme, Inc. AND Wells Fargo Bank, National Association, as Trustee INDENTURE Dated as of April [ ], 2014 [ ]% Convertible Senior Subordinated Notes due 2019 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 2 Section 1.02. References to Interest 13 Section 1.03. Incorporation by Reference of Trust Indenture Act 13 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A N

- S-3ASR

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on March 25, 2014 Registration No.

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) March 11, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is file

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

TerraVia Holdings 10-K (Annual Report)

Prepared by R.R. Donnelley Financial - 10-K Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC

- FORM S-8

FORM S-8 As filed with the Securities and Exchange Commission on March 14, 2014 Registration No.

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A 1 d685898dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) February 25, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 26, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commissio

Solazyme Reports Fourth Quarter and Full Year 2013 Results Commercial Production Underway at Clinton Moema Facility Commissioning

EX-99.1 Exhibit 99.1 Solazyme Reports Fourth Quarter and Full Year 2013 Results Commercial Production Underway at Clinton Moema Facility Commissioning South San Francisco, CA – February 26, 2014 – Solazyme, Inc. (NASDAQ: SZYM), a Renewable™ oil and bioproducts company, announced today results for the fourth quarter and full year ended December 31, 2013. “2013 was a year of great progress for Solaz

TVIA / TerraVia Holdings, Inc. / Fiddler Jerry - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

TVIA / TerraVia Holdings, Inc. / Wolfson Jonathan S - SC 13G/A Passive Investment

SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

Statement of Computation of Ratio of Earnings to Fixed Charges and Ratio of Combined Fixed Charges and Preferred Stock Dividends to Earnings (In thousands) Nine Months Ended September 30, Year Ended December 31, 2013 2012 2012 2011 2010 2009 2008 Ear

EX-12.1 Exhibit 12.1 Statement of Computation of Ratio of Earnings to Fixed Charges and Ratio of Combined Fixed Charges and Preferred Stock Dividends to Earnings (In thousands) Nine Months Ended September 30, Year Ended December 31, 2013 2012 2012 2011 2010 2009 2008 Earnings: Consolidated net loss before income tax $ (83,053 ) $ (58,522 ) $ (83,132 ) $ (53,961 ) $ (16,420 ) $ (13,815 ) $ (14,853

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

EX-25.1 7 d674903dex251.htm EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ¨ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as s

FORM OF NOTE DUE

EX-4.3 3 d674903dex43.htm EX-4.3 Exhibit 4.3 FORM OF NOTE DUE [UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF

- S-3ASR

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on February 13, 2014 Registration No.

[FORM OF SENIOR INDENTURE] SOLAZYME, INC., Issuer Wells Fargo Bank, National Association, Trustee Dated as of [—], 201[—] SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Certain Terms Defined; Rules of Construction 1

EX-4.2 Exhibit 4.2 [FORM OF SENIOR INDENTURE] SOLAZYME, INC., Issuer and Wells Fargo Bank, National Association, Trustee INDENTURE Dated as of [—], 201[—] SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Certain Terms Defined; Rules of Construction 1 ARTICLE 2 SECURITIES Section 2.01. Forms Generally 6 Section 2.02. Form of Trustee’s Certification of Authentication

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 5, 2014 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission

TVIA / TerraVia Holdings, Inc. / RODA GROUP INVESTMENT FUND XIV LLC - SCHEDULE 13D/A Activist Investment

Schedule 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* SOLAZYME, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 83415T 101 (CUSIP Number) Daniel H. Miller The Roda Group 918 Parker Street Berkeley, California 94710 (510) 649-1900 (Name, Address an

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 10, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commissio

Solazyme Reports Third Quarter 2013 Results US Manufacturing Facility (Clinton) Operating; Brazil Facility (Moema) Commissioning; Commercial Product from Both Facilities Expected in 1Q14; Initial Production of Food Ingredients at Peoria; Announced Co

EX-99.1 Exhibit 99.1 Solazyme Reports Third Quarter 2013 Results US Manufacturing Facility (Clinton) Operating; Brazil Facility (Moema) Commissioning; Commercial Product from Both Facilities Expected in 1Q14; Initial Production of Food Ingredients at Peoria; Announced Commercial Supply Agreements and Launched Second Skin-Care Brand South San Francisco, CA – November 5, 2013 – Solazyme, Inc. (NASDA

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) November 5, 2013 SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File

Submission of Matters to a Vote of Security Holders

8-K/A 1 d599458d8ka.htm AMENDMENT NO. 1 TO FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 19, 2012 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-107

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 4, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commissio

TVIA / TerraVia Holdings, Inc. / RODA GROUP INVESTMENT FUND XIV LLC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* SOLAZYME, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 83415T 101 (CUSIP Number) Daniel H. Miller The Roda Group 918 Parker Street Berkeley, California 94710 (510) 649-1900 (Name, Address and Tele

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) August 13, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 7, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission F

Solazyme Reports Second Quarter 2013 Results Solazyme Bunge Renewable Oils Production Facility on Track for Q4; Commissioning Schedule Accelerated at Clinton Facility; Announces High Erucic Tailored Oil within Mitsui JDA and Commercial Supply Terms F

EX-99.1 Exhibit 99.1 Solazyme Reports Second Quarter 2013 Results Solazyme Bunge Renewable Oils Production Facility on Track for Q4; Commissioning Schedule Accelerated at Clinton Facility; Announces High Erucic Tailored Oil within Mitsui JDA and Commercial Supply Terms Finalized with Sasol South San Francisco, CA – August 7, 2013 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts com

Termination of a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 18, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File Number

Regulation FD Disclosure, Other Events - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 24, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fi

-

CORRESP 1 filename1.htm June 13, 2013 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Attention: Terence O’Brien, Accounting Branch Chief Tracey McKoy, Staff Accountant Re: Solazyme, Inc. Form 10-K for the Year Ended December 31, 2012 Filed March 13, 2013 File No. 001-35189 Ladies and Gentlemen: Solazyme, Inc. (the “Company”) is sub

TVIA / TerraVia Holdings, Inc. / RODA GROUP INVESTMENT FUND XIV LLC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* SOLAZYME, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 83415T 101 (CUSIP Number) Daniel H. Miller The Roda Group 918 Parker Street Berkeley, California 94710 (510) 649-1900 (Name, Address and Tele

Submission of Matters to a Vote of Security Holders - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 4, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission Fil

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) May 28, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A 1 d544495dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) May 21, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 8, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission File

Solazyme Reports First Quarter 2013 Results Enters Agreement with AkzoNobel Targeting Surfactants and Coatings Markets Commercial Production Facilities on Track Further Expands Disruptive Technology Platform with New Oil Structuring Capability

EX-99.1 Exhibit 99.1 Solazyme Reports First Quarter 2013 Results Enters Agreement with AkzoNobel Targeting Surfactants and Coatings Markets Commercial Production Facilities on Track Further Expands Disruptive Technology Platform with New Oil Structuring Capability South San Francisco, CA – May 8, 2013 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced today results

- DEFINITIVE PROXY STATEMENT

Definitive Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

- DEFINITIVE ADDITIONAL MATERIALS

Definitive Additional Materials UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission F

- FORM S-8

As filed with the Securities and Exchange Commission on March 13, 2013 Registration No.

Other Events - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 11, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission F

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) March 4, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is file

TVIA / TerraVia Holdings, Inc. / Braemar Energy Ventures Ii, Lp - SC 13G/A Passive Investment

SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

JOINT FILING AGREEMENT

EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or

TVIA / TerraVia Holdings, Inc. / RODA GROUP INVESTMENT FUND XIV LLC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* SOLAZYME, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 83415T 101 (CUSIP Number) Daniel H. Miller The Roda Group 918 Parker Street Berkeley, California 94710 (510) 649-1900 (Name, Address and Tele

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 20, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commissio

Solazyme Reports Fourth Quarter and Full Year 2012 Results On Track for Commercial Production on Three Continents by 2014 Continued Development of High Value Tailored Oils Technology Proven at Commercial Scale Algenist® Sales Increase 129% in 2012

EX-99.1 Exhibit 99.1 Solazyme Reports Fourth Quarter and Full Year 2012 Results On Track for Commercial Production on Three Continents by 2014 Continued Development of High Value Tailored Oils Technology Proven at Commercial Scale Algenist® Sales Increase 129% in 2012 South San Francisco, CA – February 20, 2013 – Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, announced tod

TVIA / TerraVia Holdings, Inc. / Wolfson Jonathan S - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨

TVIA / TerraVia Holdings, Inc. / Fiddler Jerry - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨

TVIA / TerraVia Holdings, Inc. / Dillon Harrison - SC 13G Passive Investment

SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Solazyme, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 83415T101 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 13, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commissio

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 24, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission

Solazyme, Inc. Wells Fargo Bank, National Association, as Trustee Dated as of January 24, 2013 6.00% Convertible Senior Subordinated Notes due 2018 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 1 Section 1.02. References to I

Exhibit 4.1 EXECUTION VERSION Solazyme, Inc. AND Wells Fargo Bank, National Association, as Trustee INDENTURE Dated as of January 24, 2013 6.00% Convertible Senior Subordinated Notes due 2018 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 1 Section 1.02. References to Interest 12 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE OF NOTES Section 2.01. Desig

- AMENDMENT NO. 2 TO FORM S-3

S-3/A 1 d438750ds3a.htm AMENDMENT NO. 2 TO FORM S-3 Table of Contents As filed with the Securities and Exchange Commission on January 23, 2013 Registration No. 333-185461 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Solazyme, Inc. (Exact Name of Registrant as Specified in Its Charter) Del

- AMENDMENT NO. 1 TO FORM S-3

Amendment No. 1 to Form S-3 Table of Contents As filed with the Securities and Exchange Commission on January 22, 2013 Registration No. 333-185461 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Solazyme, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 33-1077078 (State

SOLAZYME, INC. PRICES OFFERING OF $115 MILLION OF 6.00% CONVERTIBLE SENIOR SUBORDINATED NOTES

Press Release Exhibit 99.1 SOLAZYME, INC. PRICES OFFERING OF $115 MILLION OF 6.00% CONVERTIBLE SENIOR SUBORDINATED NOTES South San Francisco, CA, January 18, 2013 — Solazyme, Inc. (NASDAQ: SZYM) announced today the pricing of its offering of $115 million aggregate principal amount of Convertible Senior Subordinated Notes due 2018 (the “Convertible Notes”) in a private placement under the Securitie

Financial Statements and Exhibits, Other Events - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 17, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events - FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 17, 2013 Date of report (Date of earliest event reported) SOLAZYME, INC. (Exact name of registrant as specified in its charter) Delaware 001-35189 33-1077078 (State or Other Jurisdiction of Incorporation) (Commission

1

EX-99.1 2 d467314dex991.htm RISK FACTORS Exhibit 99.1 Risks Related to Our Company Risks Related to Our Business and Industry We have a limited operating history and have incurred significant losses to date, anticipate continuing to incur losses for at least the next several years and may never achieve or sustain profitability. We are an early stage company with a limited operating history. We onl